Patents by Inventor Pierre Cordelier

Pierre Cordelier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for predicting pancreatic cancer treatment response
    Patent number: 10760135
    Abstract: The present invention relates to methods for predicting pancreatic cancer treatment response.
    Type: Grant
    Filed: January 13, 2016
    Date of Patent: September 1, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITE PAUL SABATIER TOULOUSE III, CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
    Inventors: Pierre Cordelier, Louis Buscail, Frédéric Lopez
  • CYTIDINE DEAMINASE INHIBITORS FOR THE TREATMENT OF PANCREATIC CANCER
    Publication number: 20190076464
    Abstract: The present invention relates to methods and pharmaceutical compositions for use in the treatment of pancreatic cancer in a subject in need thereof. The inventors showed that targeting cytidine deaminase sensitizes cancer cells to chemotherapy (gemcitabine dFdC) both in vitro and in vivo in experimental models of PDA, with very high efficacy. To their surprise, CDA targeting in the absence of chemotherapy strongly alters cell proliferation and tumor progression. In particular, the present invention relates to a method for treating pancreatic cancer in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a cytidine deaminase inhibitor in combination with an anti-pancreatic cancer treatment selected from the group consisting of CHK1 inhibitor, WEE1 inhibitor, ART inhibitor, DHODH inhibitor or gene therapy.
    Type: Application
    Filed: March 15, 2017
    Publication date: March 14, 2019
    Inventors: Pierre CORDELIER, Marion GAYRAL
  • METHODS FOR PREDICTING PANCREATIC CANCER TREATMENT RESPONSE
    Publication number: 20190024186
    Abstract: The present invention relates to methods for predicting pancreatic cancer treatment response.
    Type: Application
    Filed: January 13, 2016
    Publication date: January 24, 2019
    Inventors: Pierre CORDELIER, Louis BUSCAIL, Frédéric LOPEZ
  • Methods for the Diagnosis of Pancreatic Cancer
    Publication number: 20180010194
    Abstract: The present invention relates to the diagnosis of pancreatic cancer, in particular to a salivary mi RNA for use in the diagnosis of pancreatic cancer.
    Type: Application
    Filed: January 12, 2016
    Publication date: January 11, 2018
    Inventors: Pierre Cordelier, Louis Buscail, Marine Humeau
  • USE OF CELLS DERIVED FROM ADIPOSE TISSUE FOR THE PREPARATION OF AN ANTI-TUMOR MEDICAMENT
    Publication number: 20090186007
    Abstract: Use of cells isolated from extramedullary white adipose tissue, selected from the group consisting of the stromal-vascular fraction and a subpopulation of said stromal-vascular fraction consisting of adherent cells, for the preparation of an anti-tumor medicament.
    Type: Application
    Filed: May 18, 2007
    Publication date: July 23, 2009
    Inventors: Pierre Cordelier, Louis Buscail, Louis Casteilla, Beatrice Cousin-Delarue, Luc Penicaud, Jean-Marie Peron